Laverah Olukune is a dynamic leader in the pharmaceutical industry, currently serving as the Director of US Oncology Commercial Health Equity, Inclusion & Diversity at AstraZeneca. With a wealth of experience in strategic marketing and product launch campaigns across various therapeutic areas, including oncology, hematology,...
Laverah Olukune is a dynamic leader in the pharmaceutical industry, currently serving as the Director of US Oncology Commercial Health Equity, Inclusion & Diversity at AstraZeneca. With a wealth of experience in strategic marketing and product launch campaigns across various therapeutic areas, including oncology, hematology, mental health, and respiratory health, Laverah is at the forefront of AstraZeneca’s commitment to health equity and diversity in healthcare. In her current role, she is accountable for defining and driving the US Oncology Health Equity Strategy, ensuring that underserved populations receive equitable access to innovative cancer treatments.
Laverah leads the cross-functional US Oncology Inclusion & Diversity Steering Committee, where she collaborates with stakeholders across the organization to implement initiatives that foster an inclusive culture and promote diversity within the workforce. Her expertise in strategic communications and brand strategy enables her to craft compelling narratives that resonate with diverse audiences, while her strong leadership skills drive organizational effectiveness and enhance team performance.
One of her key projects involves spearheading AstraZeneca’s above-brand marketing initiatives for US Oncology's Precision Medicine approach, a groundbreaking strategy that tailors treatment options to individual patient needs. By leveraging her background in research and marketing strategy, Laverah is not only enhancing patient outcomes but also addressing systemic barriers that hinder access to care. Her commitment to health equity and inclusion positions her as a pivotal figure in transforming the landscape of oncology care, ensuring that all patients have the opportunity to benefit from the latest advancements in medicine.
